Latest news
Why Tempus AI (TEM) Is Up 18.6% After Joining CellCarta’s CDx Commercialization Lab Network - simplywall.stsimplywall.st · Sat, 08 Aug 2026 12:48:30 GMTTempus AI Expands Cancer Platform With Launch of ArteraAI Prostate Test For Metastatic Patients - StocktwitsStocktwits · Sat, 08 Aug 2026 09:15:41 GMTWhy Is Tempus AI Stock Surging on Friday? - BenzingaBenzinga · Fri, 07 Aug 2026 18:21:02 GMTTempus AI, Inc. (TEM) CEO's spouse sells 23,818 shares in plan - Stock TitanStock Titan · Wed, 05 Aug 2026 20:30:57 GMTTempus AI, Inc. (TEM) director sells 370 shares under 10b5-1 plan - Stock TitanStock Titan · Wed, 05 Aug 2026 20:30:57 GMTH.C. Wainwright cuts Tempus AI stock price target to $56 on revenue miss - Investing.com CanadaInvesting.com Canada · Tue, 04 Aug 2026 11:47:41 GMTStifel cuts Tempus AI stock price target to $50 on margin concerns - Investing.com CanadaInvesting.com Canada · Mon, 03 Aug 2026 12:56:50 GMTSpotlight On Tempus AI And 2 Other Leading Insider-Owned Growth Stocks - simplywall.stsimplywall.st · Mon, 03 Aug 2026 11:16:21 GMT